Sofosbuvir in Treatment of COVID 19

Phase 3UnknownNCT04460443

Tanta University60 enrolled

Overview

Sofosbuvir containing treatment in treatment of COVID 19 Egyptian patients

Sofosbuvir containing treatment of COVID 19 Egyptian patients: a randomized-controlled trial

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Sofosbuvir once daily

Sofosbuvir ledipsavir once daily

Daklatasuvir tablets

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Covid positive patients. Exclusion Criteria: * Contraindication to sofosbuvir or ribavirin.

Sherief Abd-Elsalam

Tanta, Egypt

RECRUITING

Number of patients with response to treatment

The total number of patients with response to treatment

Time frame: 1 month

Sherief Abd-Elsalam, ass. prof.

CONTACT

sherief abd-elsalan, ass. prof.

CONTACT

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.